Variable Column



Download 211,68 Kb.
Date conversion28.06.2017
Size211,68 Kb.
The file GAST_97.DAT contains data from the 1997 follow-up (Cycle 5) examination that were used to perform the exposure analyses for the Gastrointestinal chapter (Chapter 13 – 1997 follow-up report).


Variable

Column

Variable Type

Comment

SEQNO

1-5

Character

AFHS participant identification

ALT

6-8

Numeric

Alanine aminotransferase (ALT) (U/L)

ABSCGP

9

Character

History of liver abscess and sequelae of chronic liver disease, verified from medical records [A = abnormal (yes); N = normal (no)]

CIRALGP

10

Character

History of chronic liver disease and cirrhosis (alcohol-related), verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

CIRNAGP

11

Character

History of chronic liver disease and cirrhosis (nonalcohol-related), verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

ELIVGP

12

Character

History of enlarged liver (hepatomegaly), verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

JAUNGP

13

Character

History of jaundice (unspecified), verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

NECRGP

14

Character

History of acute and subacute necrosis of the liver, verified from medical records [A = abnormal (yes); N = normal (no)]

OLIVGP

15

Character

History of other liver disorders, verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

UNCHEPGP

16

Character

History of uncharacterized hepatitis, verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

VIRUNSGP

17

Character

History of viral and other unspecified disorders, verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

UNSPLVGP

18

Character

History of unspecified liver disorders, verified from medical records [A = abnormal (yes); N = normal (no); ‘ ‘ = pre-Southeast Asia history of condition]

IC7904GP

19

Character

History of nonspecific elevated levels of transaminase or lactic acid dehydrogenase (LDH), verified from medical records [A = abnormal (yes); N = normal (no)]

IC7905GP

20

Character

History of nonspecific abnormal serum enzyme, verified from medical records [A = abnormal (yes); N = normal (no)]

IC7948GP

21

Character

Nonspecific abnormal liver scan, verified from medical records [A = abnormal (yes); N = normal (no)]

ABSCI

22

Numeric

History of liver abscess and sequelae of chronic liver disease, verified from medical records [1 = normal (no); 2 = abnormal (yes)]

CIRALI

23

Numeric

History of chronic liver disease and cirrhosis (alcohol-related), verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

CIRNAI

24

Numeric

History of chronic liver disease and cirrhosis (nonalcohol-related), verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

ELIVI

25

Numeric

History of enlarged liver (hepatomegaly), verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

JAUNI

26

Numeric

History of jaundice (unspecified), verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

NECRI

27

Numeric

History of acute and subacute necrosis of the liver, verified from medical records [1 = normal (no); 2 = abnormal (yes)]

OLIVI

28

Numeric

History of other liver disorders, verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

UNCHEPI

29

Numeric

History of uncharacterized hepatitis, verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

VIRUNSI

30

Numeric

History of viral and other unspecified disorders, verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

UNSPLVI

31

Numeric

History of unspecified liver disorders, verified from medical records [1 = normal (no); 2 = abnormal (yes); . = pre-Southeast Asia history of condition]

IC7904I

32

Numeric

History of nonspecific elevated levels of transaminase or lactic acid dehydrogenase (LDH), verified from medical records [1 = normal (no); 2 = abnormal (yes)]

IC7905I

33

Numeric

History of nonspecific abnormal serum enzyme, verified from medical records [1 = normal (no); 2 = abnormal (yes)]

IC7948I

34

Numeric

History of nonspecific abnormal liver scan, verified from medical records [1 = normal (no); 2 = abnormal (yes)]

PSABSC

35

Character

Pre-Southeast Asia liver abscess and sequelae of chronic liver disease, verified from medical records [N = no]

PSCIRAL

36

Character

Pre-Southeast Asia chronic liver disease and cirrhosis (alcohol-related), verified from medical records [Y = yes; N = no]

PSCIRNA

37

Character

Pre-Southeast Asia chronic liver disease and cirrhosis (nonalcohol-related), verified from medical records [Y = yes; N = no]

PSELIV

38

Character

Pre-Southeast Asia enlarged liver (hepatomegaly), verified from medical records [Y = yes; N = no]

PSJAUN

39

Character

Pre-Southeast Asia jaundice (unspecified), verified from medical records [Y = yes; N = no]

PSNECR

40

Character

Pre-Southeast Asia acute and subacute necrosis of the liver, verified from medical records [N = no]

PSOLIV

41

Character

Pre-Southeast Asia other liver disorders, verified from medical records [Y = yes; N = no]

PSUNCHEP

42

Character

Pre-Southeast Asia uncharacterized hepatitis, verified from medical records [Y = yes; N = no]

PSVIRUNS

43

Character

Pre-Southeast Asia viral and other unspecified disorders, verified from medical records [Y = yes; N = no]

PSUNSPLV

44

Character

Pre-Southeast Asia unspecified liver disorders, verified from medical records [Y = yes; N = no]

PSIC7904

45

Character

Pre-Southeast Asia nonspecific elevated levels of transaminase or lactic acid dehydrogenase (LDH), verified from medical records [N = no]

PSIC7905

46

Character

Pre-Southeast Asia abnormal serum enzyme, verified from medical records [N = no]

PSIC7948

47

Character

Pre-Southeast Asia abnormal liver scan, verified from medical records [N = no]

EXPGP

48-52

Character

Exposure group [a) RH = Ranch Hand; b) C = Comparison]

EXPI

53

Numeric

Exposure group [1 = Ranch Hand; 2 = Comparison]

BDATE

54-63

Character

Date of birth (month/day/year)

AGE

64-69

Numeric

Age at the 1997 physical exam (years)

AGEGP

70-83

Character

Age at the 1997 physical exam [1) BORN < 1942; 2) BORN >= 1942]

AGEI

84

Numeric

Age at the 1997 physical exam [1 = born before 1942; 2 = born in or after 1942]

RACEGP

85-89

Character

Race [1) BL = Black; 2) NB = non-Black]

RACEI

90

Numeric

Race [1 = Black; 2 = non-Black]

OCCGP

91-96

Character

Occupation [1) OFF = officer; 2) EFL = enlisted flyer; 3) EGC = enlisted groundcrew]

OCCI

97

Numeric

Occupation [1 = officer; 2 = enlisted flyer; 3 = enlisted groundcrew]

DRKYR

98-104

Numeric

Lifetime alcohol history (drink-years) [. = missing]

LWINE

105-111

Numeric

Lifetime wine history (drink-years of wine) [. = missing]

CALC

112-117

Numeric

Current alcohol use (drinks/day) [. = missing]

CWINE

118-122

Numeric

Current wine consumption (drinks of wine/day) [. = missing]

CALCGP

123-131

Character

Current alcohol use (drinks/day) [1) 0 – 1; 2) >1 – 4; 3) >4; ‘ ‘ = missing]

CALCI

132

Numeric

Current alcohol use (drinks/day) [1 = 0 – 1; 2 = >1 – 4; 3 = >4; . = missing]

DRKYRGP

133-142

Character

Lifetime alcohol history (drink-years) [1) 0; 2) >0 – 40; 3) >40; ‘ ‘ = missing]

DRKYRI

143

Numeric

Lifetime alcohol history (drink-years) [1 = 0; 2 = >0 – 40; 3 = >40; . = missing]

CWINEGP

144-148

Character

Current wine consumption (drinks of wine/day) [1) 0; 2) >0; ‘ ‘ = missing]

CWINEI

149

Numeric

Current wine consumption (drinks of wine/day) [1 = 0; 2 = >0; . = missing]

LWINEGP

150-154

Character

Lifetime wine history (drink-years of wine) [1) 0; 2) >0; ‘ ‘ = missing]

LWINEI

155

Numeric

Lifetime wine history (drink-years of wine) [1 = 0; 2 = >0; . = missing]

DGCHEMI

156

Numeric

Degreasing chemical exposure [1 = yes; 2 = no]

INCHEMI

157

Numeric

Industrial chemical exposure [1 = yes; 2 = no]

DGCHEMGP

158-161

Character

Degreasing chemical exposure [1) Y = yes; 2) N = no]

INCHEMGP

162-165

Character

Industrial chemical exposure [1) Y = yes; 2) N = no]

HBSAG

166

Character

Hepatitis B surface antigen (current hepatitis B) [Y = yes; N = no]

HEPC

167

Character

Hepatitis C antibodies [Y = yes; N = no]

HEPD

168

Character

Hepatitis D antibodies [Y = yes; N = no]

ID

169

Character

Exposure group (for participants with a dioxin assay) [C = Comparison; R = Ranch Hand; ‘ ‘ = no dioxin assay]

REPORT

170-172

Character

Results of dioxin analysis (for participants with a dioxin assay and a good result) [G= good result; GND = good result, below limit of detection; ‘ ‘ = missing]

CURRENT

173-178

Numeric

1987 lipid-adjusted dioxin level (actual measurement or 1987 level extrapolated from dioxin measurement closest to time of duty in Southeast Asia - for participants with a dioxin assay and a good result) (parts per trillion (ppt)) [. = missing]

REPTYR

179-180

Character

Year from which assay is used for dioxin determination (for participants with a dioxin assay and a good result) [87 = 1987; 92 = 1992; 97 = 1997; P = pilot test (conducted in 1987) ; ‘ ‘ = missing]


INITIAL

181-187

Numeric

Initial dioxin estimate (parts per trillion (ppt)), extrapolated from 1987 or recent lipid-weight dioxin measurement for Ranch Hands with a 1987 or recent measurement > 10 ppt [. = missing or not calculated]

LOGINIT

188-204

Numeric

Log (base 2) of initial dioxin for Ranch Hands with a 1987 or recent measurement > 10 ppt [. = missing or not calculated]

PBFDBDRW

205-219

Numeric

Body fat (percent) at time of dioxin blood draw for participants with a dioxin assay and a good result [. = missing]

LGINITGP

220-228

Character

Log (base 2) of initial dioxin for Ranch Hands with a 1987 or recent measurement > 10 ppt [1) LOW (initial dioxin: 27 - 63 ppt); 2) MEDIUM (initial dioxin: >63 – 152 ppt); 3) HIGH (initial dioxin: >152 ppt); ‘ ‘ = missing or not calculated]

LGINITI

229

Numeric

Log (base 2) of initial dioxin for Ranch Hands with a 1987 or recent measurement > 10 ppt [1 = low (initial dioxin: 27 - 63 ppt); 2 = medium (initial dioxin: >63 – 152 ppt); 3 = high (initial dioxin: >152 ppt); . = missing or not calculated]

DXCATGP

230-240

Character

Categorized dioxin [1) COMP<=10 (Comparisons: 1987 dioxin  10 ppt); 2) RH <=10 (background Ranch Hands: 1987 dioxin  10 ppt); 3) LOW RH (Ranch Hands: 1987 dioxin > 10 ppt and initial dioxin >10 - 94 ppt); 4) HIGH RH (Ranch Hands: 1987 dioxin >10 ppt and initial dioxin > 94 ppt); ‘ ‘ = missing or Comparisons with 1987 dioxin > 10 ppt]

DXCAT2GP

241-251

Character

Categorized dioxin [a) RH <=10 (background Ranch Hands: 1987 dioxin  10 ppt); b) LOW RH (Ranch Hands: 1987 dioxin > 10 ppt and initial dioxin >10 - 94 ppt); c) HIGH RH (Ranch Hands: 1987 dioxin >10 ppt and initial dioxin >94 ppt); d) COMP<=10 (Comparisons: 1987 dioxin  10 ppt); ‘ ‘ = missing or Comparisons with 1987 dioxin > 10 ppt]

DXCAT3GP

252-267

Character

Categorized dioxin [1) COMP<=10 (Comparisons: 1987 dioxin  10 ppt); 2) RH <=10 (background Ranch Hands: 1987 dioxin  10 ppt); 3) LOW + HIGH RH (Ranch Hands: 1987 dioxin > 10 ppt and initial dioxin > 10 ppt); ‘ ‘ = missing or Comparisons with 1987 dioxin > 10 ppt]

DXCATI

268

Numeric

Categorized dioxin [1 = Comparisons: 1987 dioxin  10 ppt; 2 = background Ranch Hands: 1987 dioxin  10 ppt; 3 = low Ranch Hands: 1987 dioxin > 10 ppt and initial dioxin >10 - 94 ppt; 4 = high Ranch Hands: 1987 dioxin >10 ppt and initial dioxin > 94 ppt; . = missing or Comparisons with 1987 dioxin > 10 ppt]

DXCAT2I

269

Numeric

Categorized dioxin [1 = background Ranch Hands: 1987 dioxin  10 ppt; 2 = low Ranch Hands: 1987 dioxin > 10 ppt and initial dioxin >10 – 94 ppt; 3 = high Ranch Hands: 1987 dioxin >10 ppt and initial dioxin >94 ppt; 4 = Comparisons: 1987 dioxin  10 ppt; . = missing or Comparisons with 1987 dioxin > 10 ppt]

DXCAT3I

270

Numeric

Categorized dioxin [1 = Comparisons: 1987 dioxin  10 ppt; 2 = background Ranch Hands: 1987 dioxin  10 ppt; 3 = low plus high Ranch Hands: 1987 dioxin > 10 ppt and initial dioxin > 10 ppt; . = missing or Comparisons with 1987 dioxin > 10 ppt]

LGCURRGP

271-279

Character

For Ranch Hands with a dioxin assay and a good result: [1) LOW (1987 dioxin:  7.9 ppt); 2) MEDIUM (1987 dioxin > 7.9 – 19.6 ppt); 3) HIGH (1987 dioxin > 19.6 ppt); ‘ ‘ = missing (includes Comparisons)]

LGCURRI

280

Numeric

For Ranch Hands with a dioxin assay and a good result: [1 = low (1987 dioxin:  7.9 ppt); 2 = medium (1987 dioxin: >7.9 – 19.6 ppt); 3 = high (1987 dioxin >19.6 ppt); . = missing (includes Comparisons)]

LOGCURR

281-296

Numeric

Log (base 2) of (1987 dioxin + 1) for Ranch Hands with a dioxin assay and a good result [. = missing (includes Comparisons)]

FEVER

297

Character

Temperature 100 degrees Fahrenheit at time of the physical examination [Y = yes; N = no]

HEPBVACC

298

Character

Vaccinated for hepatitis B [Y = yes; N = no]

BFAT97

299-304

Numeric

1997 body fat (percent)

HEPTOMGP

305

Character

Current hepatomegaly (physical examination) [A = abnormal (yes); N = normal (no)]

HEPTOMI

306

Numeric

Current hepatomegaly (physical examination) [1 = normal (no); 2 = abnormal (yes)]

AST

307-309

Numeric

Aspartate aminotransferase (AST) (U/L)

ASTGP

310

Character

Aspartate aminotransferase (AST) [A = abnormal (high: >37 U/L); N = normal (37 U/L)]

ASTI

311

Numeric

Aspartate aminotransferase (AST) [1 = normal (37 U/L); 2 = abnormal (high: >37 U/L)]

ALTGP

312

Character

Alanine aminotransferase (ALT) [A = abnormal (high: >65 U/L); N = normal (65 U/L)]

ALTI

313

Numeric

Alanine aminotransferase (ALT) [1 = normal (65 U/L); 2 = abnormal (high: >65 U/L)]

GGT

314-316

Numeric

Gamma glutamyl transferase (GGT) (U/L)

GGTGP

317

Character

Gamma glutamyl transferase (GGT) [A = abnormal (high: >85 U/L); N = normal (85 U/L)]

GGTI

318

Numeric

Gamma glutamyl transferase (GGT) [1 = normal (85 U/L); 2 = abnormal (high: >85 U/L)]

ALKAPH

319-321

Numeric

Alkaline phosphatase (U/L)

ALKAPHGP

322

Character

Alkaline phosphatase [A = abnormal (high: >136 U/L); N = normal (136 U/L)]

ALKAPHI

323

Numeric

Alkaline phosphatase [1 = normal (136 U/L); 2 = abnormal (high: >136 U/L)]

TBILI

324-326

Numeric

Total bilirubin (mg/dl)

TBILIGP

327

Character

Total bilirubin [A = abnormal (high: >1.0 mg/dl); N = normal (1.0 mg/dl)]

TBILII

328

Numeric

Total bilirubin [1 = normal (1.0 mg/dl); 2 = abnormal (high: >1.0 mg/dl)]

DBILIGP

329

Character

Direct bilirubin [A = abnormal (high: >0.3 mg/dl); N = normal (0.3 mg/dl)]

DBILII

330

Numeric

Direct bilirubin [1 = normal (0.3 mg/dl); 2 = abnormal (high: >0.3 mg/dl)]

LDH

331-333

Numeric

Lactic dehydrogenase (LDH) (U/L) [ . = missing]

LDHGP

334

Character

Lactic dehydrogenase (LDH) [A = abnormal (high: >190 U/L); N = normal (190 U/L); ‘ ‘ = missing]

LDHI

335

Numeric

Lactic dehydrogenase (LDH) [1 = normal (190 U/L); 2 = abnormal (high: >190 U/L); . = missing]

CHOLGP

336

Character

Cholesterol [A = abnormal (high: >260 mg/dl for participants 45 to 49 years old, >250 mg/dl for participants 50 years and older); N = normal (260 mg/dl for participants 45 to 49 years old, 250 mg/dl for participants 50 years and older)]

CHOLI

337

Numeric

Cholesterol [1 = normal (260 mg/dl for participants 45 to 49 years old, 250 mg/dl for participants 50 years and older); 2 = abnormal (high: >260 mg/dl for participants 45 to 49 years old, >250 mg/dl for participants 50 years and older]

CHOL

338-340

Numeric

Cholesterol (mg/dl)

HDL

341-343

Numeric

High density lipoprotein (HDL) cholesterol (mg/dl) [ . = not performed due to elevated triglyceride level]

HDLGP

344

Character

High density lipoprotein (HDL) cholesterol [A = abnormal (low: <32 mg/dl); N = normal ( 32 mg/dl); ‘ ‘ = not performed due to elevated triglyceride level]

HDLI

345

Numeric

High density lipoprotein (HDL) cholesterol [1 = normal ( 32 mg/dl); 2 = abnormal (low: < 32 mg/dl); . = not performed due to elevated triglyceride level]

CHLRAT

346-362

Numeric

Cholesterol-HDL ratio [ . = not calculated due to elevated triglyceride level]

CHLRATGP

363

Character

Cholesterol-HDL ratio [A = abnormal (high: >5); N = normal (5); ‘ ‘ = not calculated due to elevated triglyceride level]

CHLRATI

364

Numeric

Cholesterol-HDL ratio [1 = normal (5); 2 = abnormal (high: >5); . = not calculated due to elevated triglyceride level]

TRIGLY

365-368

Numeric

Triglycerides (mg/dl) [ . = missing]

TRIGLYGP

369

Character

Triglycerides [A = abnormal (high: >200 mg/dl); N = normal (200 mg/dl); ‘ ‘ = missing]

TRIGLYI

370

Numeric

Triglycerides [1 = normal (200 mg/dl); 2 = abnormal (high: >200 mg/dl); . = missing]

CPHKI

371-374

Numeric

Creatine (phospho)kinase (U/L)

CPHKIGP

375

Character

Creatine (phospho)kinase [A = abnormal (high: >232 U/L); N = normal (232 U/L)]

CPHKII

376

Numeric

Creatine (phospho)kinase [1 = normal (232 U/L); 2 = abnormal (high: >232 U/L)]

AMYL

377-379

Numeric

Serum amylase (U/L)

AMYLGP

380

Character

Serum amylase [A = abnormal (high: >115 U/L); N = normal (115 U/L)]

AMYLI

381

Numeric

Serum amylase [1 = normal (115 U/L); 2 = abnormal (high: >115 U/L)]

HEPAGP

382

Character

Antibodies for hepatitis A [A = abnormal (yes); N = normal (no); ‘ ‘ = indeterminate – borderline reactive]

HEPAI

383

Numeric

Antibodies for hepatitis A [1 = normal (no); 2 = abnormal (yes); . = indeterminate – borderline reactive]

CRHEPBGP

384

Character

Current hepatitis B [A = abnormal (yes); N = normal (no)]

CRHEPBI

385

Numeric

Current hepatitis B [1 = normal (no); 2 = abnormal (yes)]

HEPBGP

386

Character

Serological evidence of prior hepatitis B infection (antibodies for hepatitis B) [A = abnormal (yes); N = normal (no); ‘ ‘ = indeterminate – borderline reactive]

HEPBI

387

Numeric

Serological evidence of prior hepatitis B infection (antibodies for hepatitis B) [1 = normal (no); 2 = abnormal (yes); . = indeterminate – borderline reactive]

HEPCGP

388

Character

Antibodies for hepatitis C [A = abnormal (yes); N = normal (no)]

HEPCI

389

Numeric

Antibodies for hepatitis C [1 = normal (no); 2 = abnormal (yes)]

HEPDGP

390

Character

Antibodies for hepatitis D [A = abnormal (yes); N = normal (no)]

HEPDI

391

Numeric

Antibodies for hepatitis D [1 = normal (no); 2 = abnormal (yes)]

STHEMGP

392

Character

Stool hemoccult [A = abnormal (yes); N = normal (no); ‘ ‘ = missing]

STHEMI

393

Numeric

Stool hemoccult [1 = normal (no); 2 = abnormal (yes); . = missing]

PREALB

394-398

Numeric

Prealbumin (mg/dl) (observations below detection limit set equal to detection limit)

PREALBGP

399

Character

Prealbumin [A = abnormal (low: <18 mg/dl); N = normal (18 mg/dl)]

PREALBI

400

Numeric

Prealbumin [1 = normal (18 mg/dl); 2 = abnormal (low: <18 mg/dl)]

PREALBDT

401-402

Character

Prealbumin [DT = observation at or above detection limit (7 mg/dl); ND = observation below detection limit (<7 mg/dl)]


ALBUM

403-406

Numeric

Albumin (mg/dl)

ALBUMGP

407

Character

Albumin [A = abnormal (low: <3,350 mg/dl); N = normal (3,350 mg/dl)]

ALBUMI

408

Numeric

Albumin [1 = normal (3,350 mg/dl); 2 = abnormal (low: <3,350 mg/dl)]

GLYCODT

409-410

Character

-1-acid glycoprotein [DT = observation at or above detection limit (35 mg/dl); ND = observation below detection limit (<35 mg/dl)]

GLYCO

411-413

Numeric

-1-acid glycoprotein (mg/dl) (observations below detection limit set equal to detection limit)

GLYCOGP

414

Character

-1-acid glycoprotein [A = abnormal (high: >125 mg/dl); N = normal (125 mg/dl)]

GLYCOI

415

Numeric

-1-acid glycoprotein [1 = normal (125 mg/dl); 2 = abnormal (high: >125 mg/dl)]

ANTRYP

416-418

Numeric

-1-antitrypsin (mg/dl)

ANTRYPGP

419-434

Character

-1-antitrypsin [ a) ABNORMAL LOW (<93 mg/dl); b) ABNORMAL HIGH (>224 mg/dl); c) NORMAL (93 - 224 mg/dl)]

ANTRYPI

435

Numeric

-1-antitrypsin [1 = normal (93 - 224 mg/dl); 2 = abnormal low (<93 mg/dl); 3 = abnormal high (>224 mg/dl)]

MCRGLDT

436-437

Character

-2-macroglobulin [DT = observation at or above detection limit (75 mg/dl); ND = observation below detection limit (<75 mg/dl)]

MCRGL

438-440

Numeric

-2-macroglobulin (mg/dl) (observations below detection limit set equal to detection limit)

MCRGLGP

441

Character

-2-macroglobulin [A = abnormal (high: >293 mg/dl); N = normal (293 mg/dl)]

MCRGLI

442

Numeric

-2-macroglobulin [1 = normal (293 mg/dl); 2 = abnormal (high: >293 mg/dl)]

APOLPDT

443-444

Character

Apolipoprotein B [DT = observation at or above detection limit (35 mg/dl); ND = observation below detection limit (<35 mg/dl)]

APOLP

445-447

Numeric

Apolipoprotein B (mg/dl) (observations below detection limit set equal to detection limit)

APOLPGP

448

Character

Apolipoprotein B [A = abnormal (high: >109 mg/dl); N = normal (109 mg/dl)]

APOLPI

449

Numeric

Apolipoprotein B [1 = normal (109 mg/dl); 2 = abnormal (high: >109 mg/dl)]

C3COMP

450-452

Numeric

C3 complement (mg/dl)

C3COMPGP

453

Character

C3 complement [A = abnormal (low: <85 mg/dl); N = normal (85 mg/dl)]

C3COMPI

454

Numeric

C3 complement [1 = normal (85 mg/dl); 2 = abnormal (low: <85 mg/dl)]

C4COMPDT

455-456

Character

C4 complement [DT = observation at or above detection limit (10 mg/dl); ND = observation below detection limit (<10 mg/dl)]

C4COMP

457-458

Numeric

C4 complement (mg/dl) (observations below detection limit set equal to detection limit)

C4COMPGP

459

Character

C4 complement [A = abnormal (low: <12 mg/dl); N = normal (12 mg/dl)]

C4COMPI

460

Numeric

C4 complement [1 = normal (12 mg/dl); 2 = abnormal (low: <12 mg/dl)]

HAPTODT

461-462

Character

Haptoglobin [DT = observation at or above detection limit (6 mg/dl); ND = observation below detection limit (<6 mg/dl)]

HAPTO

463-465

Numeric

Haptoglobin (mg/dl) (observations below detection limit set equal to detection limit)

HAPTOGP

466

Character

Haptoglobin [A = abnormal (high: >163 mg/dl); N = normal (163 mg/dl)]

HAPTOI

467

Numeric

Haptoglobin [1 = normal (163 mg/dl); 2 = abnormal (high: >163 mg/dl)]

TRANSF

468-470

Numeric

Transferrin (mg/dl)

TRANSFGP

471

Character

Transferrin [A = abnormal (low: <212 mg/dl); N = normal (212 mg/dl)]

TRANSFI

472

Numeric

Transferrin [1 = normal (212 mg/dl); 2 = abnormal (low: <212 mg/dl)]











The database is protected by copyright ©sckool.org 2016
send message

    Main page